208 related articles for article (PubMed ID: 12695489)
1. Interleukin (IL)-15R[alpha]-deficient natural killer cells survive in normal but not IL-15R[alpha]-deficient mice.
Koka R; Burkett PR; Chien M; Chai S; Chan F; Lodolce JP; Boone DL; Ma A
J Exp Med; 2003 Apr; 197(8):977-84. PubMed ID: 12695489
[TBL] [Abstract][Full Text] [Related]
2. IL-15R alpha expression on CD8+ T cells is dispensable for T cell memory.
Burkett PR; Koka R; Chien M; Chai S; Chan F; Ma A; Boone DL
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4724-9. PubMed ID: 12671073
[TBL] [Abstract][Full Text] [Related]
3. STAT1 Isoforms Differentially Regulate NK Cell Maturation and Anti-tumor Activity.
Meissl K; Simonović N; Amenitsch L; Witalisz-Siepracka A; Klein K; Lassnig C; Puga A; Vogl C; Poelzl A; Bosmann M; Dohnal A; Sexl V; Müller M; Strobl B
Front Immunol; 2020; 11():2189. PubMed ID: 33042133
[TBL] [Abstract][Full Text] [Related]
4. The roles of different forms of IL-15 in human melanoma progression.
Di Matteo S; Munari E; Fiore PF; Santopolo S; Sampaoli C; Pelosi A; Chouaib S; Tumino N; Vacca P; Mariotti FR; Ebert S; Machwirth M; Haas D; Pezzullo M; Pietra G; Grottoli M; Buart S; Mortier E; Maggi E; Moretta L; Caruana I; Azzarone B
Front Immunol; 2023; 14():1183668. PubMed ID: 37334356
[TBL] [Abstract][Full Text] [Related]
5. Characterization and favorable in vivo properties of heterodimeric soluble IL-15·IL-15Rα cytokine compared to IL-15 monomer.
Chertova E; Bergamaschi C; Chertov O; Sowder R; Bear J; Roser JD; Beach RK; Lifson JD; Felber BK; Pavlakis GN
J Biol Chem; 2013 Jun; 288(25):18093-103. PubMed ID: 23649624
[TBL] [Abstract][Full Text] [Related]
6. IFNs Drive Development of Novel IL-15-Responsive Macrophages.
Gordon SM; Nishiguchi MA; Chase JM; Mani S; Mainigi MA; Behrens EM
J Immunol; 2020 Aug; 205(4):1113-1124. PubMed ID: 32690654
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic cell-derived IL-15 supports NK cell development in scattered and clustered localization within the bone marrow.
Abe S; Asahi T; Hara T; Cui G; Shimba A; Tani-Ichi S; Yamada K; Miyazaki K; Miyachi H; Kitano S; Nakamura N; Kikuta J; Vandenbon A; Miyazaki M; Yamada R; Ohteki T; Ishii M; Sexl V; Nagasawa T; Ikuta K
Cell Rep; 2023 Sep; 42(9):113127. PubMed ID: 37729919
[TBL] [Abstract][Full Text] [Related]
8. MEF2C regulates NK cell effector functions through control of lipid metabolism.
Li JH; Zhou A; Lee CD; Shah SN; Ji JH; Senthilkumar V; Padilla ET; Ball AB; Feng Q; Bustillos CG; Riggan L; Greige A; Divakaruni AS; Annese F; Cooley Coleman JA; Skinner SA; Cowan CW; O'Sullivan TE
Nat Immunol; 2024 May; 25(5):778-789. PubMed ID: 38589619
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow monocytes sustain NK cell-poiesis during non-alcoholic steatohepatitis.
Bourayou E; Perchet T; Meunier S; Bouvier H; Mailhe MP; Melanitou E; Cumano A; Golub R
Cell Rep; 2024 Jan; 43(1):113676. PubMed ID: 38217855
[TBL] [Abstract][Full Text] [Related]
10. Membrane Potential Distinctly Modulates Mobility and Signaling of IL-2 and IL-15 Receptors in T Cells.
Nagy É; Mocsár G; Sebestyén V; Volkó J; Papp F; Tóth K; Damjanovich S; Panyi G; Waldmann TA; Bodnár A; Vámosi G
Biophys J; 2018 May; 114(10):2473-2482. PubMed ID: 29754714
[TBL] [Abstract][Full Text] [Related]
11. Signalling mechanisms driving homeostatic and inflammatory effects of interleukin-15 on tissue lymphocytes.
Skariah N; James OJ; Swamy M
Discov Immunol; 2024; 3(1):kyae002. PubMed ID: 38405398
[TBL] [Abstract][Full Text] [Related]
12. Cutting edge: murine dendritic cells require IL-15R alpha to prime NK cells.
Koka R; Burkett P; Chien M; Chai S; Boone DL; Ma A
J Immunol; 2004 Sep; 173(6):3594-8. PubMed ID: 15356102
[TBL] [Abstract][Full Text] [Related]
13. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation.
Lodolce JP; Boone DL; Chai S; Swain RE; Dassopoulos T; Trettin S; Ma A
Immunity; 1998 Nov; 9(5):669-76. PubMed ID: 9846488
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor Foxo1 is a negative regulator of natural killer cell maturation and function.
Deng Y; Kerdiles Y; Chu J; Yuan S; Wang Y; Chen X; Mao H; Zhang L; Zhang J; Hughes T; Deng Y; Zhang Q; Wang F; Zou X; Liu CG; Freud AG; Li X; Caligiuri MA; Vivier E; Yu J
Immunity; 2015 Mar; 42(3):457-70. PubMed ID: 25769609
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells prime natural killer cells by trans-presenting interleukin 15.
Lucas M; Schachterle W; Oberle K; Aichele P; Diefenbach A
Immunity; 2007 Apr; 26(4):503-17. PubMed ID: 17398124
[TBL] [Abstract][Full Text] [Related]
16. Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}.
Rubinstein MP; Kovar M; Purton JF; Cho JH; Boyman O; Surh CD; Sprent J
Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9166-71. PubMed ID: 16757567
[TBL] [Abstract][Full Text] [Related]
17. Differential roles for IL-15R alpha-chain in NK cell development and Ly-49 induction.
Kawamura T; Koka R; Ma A; Kumar V
J Immunol; 2003 Nov; 171(10):5085-90. PubMed ID: 14607906
[TBL] [Abstract][Full Text] [Related]
18. No time to die: Epigenetic regulation of natural killer cell survival.
Hermans L; O'Sullivan TE
Immunol Rev; 2024 May; 323(1):61-79. PubMed ID: 38426615
[TBL] [Abstract][Full Text] [Related]
19. Effect of low skeletal muscle mass on NK cells in patients with acute myeloid leukemia and its correlation with prognosis.
Cui J; Zhao M; Liu W; Hong M; Qian S; Sun Q
Ann Hematol; 2024 Mar; 103(3):771-780. PubMed ID: 38294533
[TBL] [Abstract][Full Text] [Related]
20. Natural Killer Cells, as the Rising Point in Tissues, Are Forgotten in the Kidney.
Ma K; Zheng ZR; Meng Y
Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
